[EN] SUBSTITUTED 3-PYRIDYL THIOPHENES AS C17,20 LYASE INHIBITORS<br/>[FR] 3-PYRIDYL THIOPHENES SUBSTITUES EN TANT QU'INHIBITEURS DE LA LYASE C17,20
申请人:BAYER AG
公开号:WO2003027105A1
公开(公告)日:2003-04-03
The invention provides novel substituted 3-pyridyl thiophenes and pharmaceutical compositions thereof. The invention also provides methods of use of substituted 3-pyridyl thiophenes, and pharmaceutical compositions thereof, as inhibitors of lyases, e.g., the 17α-hydroxylase-C17,20 enzyme. The invention further provides methods for the treatment of cancer in a subject, comprising administering a substituted 3-pyridyl thiophenes, or a pharmaceutical composition comprising a substituted 3-pyridyl thiophenes to a subject. The cancer can be, e.g., prostate cancer or breast cancer.
本发明提供了一种新型的取代3-吡啶基噻吩衍生物及其医药组合物。本发明还提供了取代3-吡啶基噻吩衍生物及其医药组合物作为裂合酶抑制剂的用途,例如作为17α-羟化酶-C17,20酶的抑制剂。本发明进一步提供了一种针对受试者治疗癌症的方法,包括向受试者施用取代3-吡啶基噻吩衍生物或含有取代3-吡啶基噻吩衍生物的医药组合物。所述癌症可以是例如前列腺癌或乳腺癌。